Characteristics of Serotype 3 Invasive Pneumococcal Disease before and after Universal Childhood Immunization with PCV13 in Massachusetts

Background: Although a substantial decline in vaccine-serotype invasive pneumococcal disease (IPD) incidence was observed following the introduction of pneumococcal conjugate vaccines (PCV), the estimated range of thirteen-valent conjugate vaccine (PCV13) effectiveness for serotype 3 disease is wide...

Full description

Bibliographic Details
Published in:	Pathogens
Main Authors:	Rotem Lapidot, Kimberly M. Shea, Inci Yildirim, Howard J. Cabral, Stephen I. Pelton, the Massachusetts Department of Public Health
Format:	Article
Language:	English
Published:	MDPI AG 2020-05-01
Subjects:	<i>Streptococcus pneumoniae serotype 3</i> PCV13 invasive pneumococcal disease
Online Access:	https://www.mdpi.com/2076-0817/9/5/396

Similar Items

Comparative Analysis of Pneumococcal Serotypes for 10 Years (2014–2024) in the Comunidad Valenciana Region, Spain, and How They Are Correlated with PCV13, PCV20, and PCV21
by: Laura Diab-Casares, et al.
Published: (2025-09-01)

Serotype Distribution of Remaining Pneumococcal Meningitis in the Mature PCV10/13 Period: Findings from the PSERENADE Project
by: Maria Garcia Quesada, et al.
Published: (2021-04-01)

Effect of Childhood Pneumococcal Conjugate Vaccination on Invasive Disease Serotypes in Serbia
by: Nataša Opavski, et al.
Published: (2024-08-01)

The 13-valent pneumococcal conjugate vaccine (PCV13) does not appear to provide much protection on combined invasive disease due to the six PCV13 non-PCV7 serotypes 1, 3, 5, 6A, 7F, and 19A in Kuwait during 2010–2019
by: Eiman Mokaddas, et al.
Published: (2021-11-01)

Impact of PCV10 on pediatric pneumococcal disease burden in Brazil: time for new recommendations?
by: Daniel Jarovsky, et al.
Published: (2023-03-01)

Exploring the evidence behind the comparable impact of the pneumococcal conjugate vaccines PHiD-CV and PCV13 on overall pneumococcal disease
by: Patricia Izurieta, et al.
Published: (2022-01-01)

Serotype epidemiology and case-fatality risk of invasive pneumococcal disease: a nationwide population study from Switzerland, 2012–2022
by: Werner C. Albrich, et al.
Published: (2025-12-01)

Pneumococcal Serotypes Associated with Community-Acquired Pneumonia Hospitalizations in Adults in Spain, 2016–2020: The CAPA Study
by: Rosario Menéndez, et al.
Published: (2023-11-01)

Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease in Greenland
by: Kristiana Alexandrova Nikolova, et al.
Published: (2021-10-01)

The impact of pneumococcal serotype replacement on the effectiveness of a national immunization program: a population-based active surveillance cohort study in New ZealandResearch in context
by: Andrew Anglemyer, et al.
Published: (2024-05-01)

Back to the future? Drastic drop in serotype 19A carriage in daycare centers within two years after a second switch to PCV13 in Belgium
by: Esra Ekinci, et al.
Published: (2025-12-01)

Changing Landscape of Invasive Pneumococcal Disease Serotypes and Antimicrobial Resistance Following Pneumococcal Conjugate Vaccine Introduction in the Middle East and North Africa Region: A Systematic Review
by: Zeinab El Zein, et al.
Published: (2025-08-01)

Changes in invasive pneumococcal disease serotypes in a regional area of Australia following three years of 7vPCV introduction
by: Fakhrul Islam, et al.
Published: (2012-06-01)

Changes in Invasive Pneumococcal Disease Caused by <em>Streptococcus pneumoniae</em> Serotype 1 following Introduction of PCV10 and PCV13: Findings from the PSERENADE Project
by: Julia C. Bennett, et al.
Published: (2021-03-01)

Pneumococcal Serotype Evolution and Burden in European Adults in the Last Decade: A Systematic Review
by: Rita Teixeira, et al.
Published: (2023-05-01)

Cost-effectiveness analysis of 20-valent pneumococcal conjugate vaccine (PCV20) to prevent pneumococcal disease in the Greek pediatric population
by: Charalampos Tzanetakos, et al.
Published: (2025-12-01)

Serotype Changes and Drug Resistance in Invasive Pneumococcal Diseases in Adults after Vaccinations in Children, Japan, 2010–2013
by: Kimiko Ubukata, et al.
Published: (2015-11-01)

Epidemiology of Serotype 1 Invasive Pneumococcal Disease, South Africa, 2003–2013
by: Claire von Mollendorf, et al.
Published: (2016-02-01)

IAPSM’s Position Paper on Pneumococcal Vaccine (PCV) for Adult Immunization in India
by: Chythra R. Rao, et al.
Published: (2024-12-01)

Analysis of pneumococcal serotypes distribution to determine a model composition for a Russian pneumococcal conjugate vaccine
by: V. P. Trukhin, et al.
Published: (2022-07-01)

Real-World Impact of Pneumococcal Conjugate Vaccines on Vaccine Serotypes and Potential Cross-Reacting Non-Vaccine Serotypes
by: Kevin Apodaca, et al.
Published: (2025-06-01)

Pneumococcal conjugate vaccines in Latin America: are PCV10 and PCV13 similar in terms of protection against serotype 19A?
by: Maria L. Avila-Aguero, et al.
Published: (2017-07-01)

Emerging pneumococcal serotypes in Iraq: scope for improved vaccine development [version 2; peer review: 2 approved]
by: Ahmed H. Radhi, et al.
Published: (2023-12-01)

Streptococcus pneumoniae serotypes and factors associated with antimicrobial resistance in Invasive pneumococcal disease cases in Latvia, 2012–2022
by: Larisa Savrasova, et al.
Published: (2025-03-01)

Serotype and molecular diversity of nasopharyngeal Streptococcus pneumoniae isolates from children before and after vaccination with the ten-valent pneumococcal conjugate vaccine (PCV10) in Ethiopia
by: Wondewosen Tsegaye Sime, et al.
Published: (2019-05-01)

The Health and Economic Effects of PCV15 and PCV20 During the First Year of Life in the US
by: Aleksandar Ilic, et al.
Published: (2024-11-01)

Historical Population-Level Impact of Infant 13-Valent Pneumococcal Conjugate Vaccine (PCV13) National Immunization Programs on Invasive Pneumococcal Disease in Australia, Canada, England and Wales, Israel, and the United States
by: Johnna Perdrizet, et al.
Published: (2023-04-01)

Knowledge of caregivers regarding pneumococcal diseases and pneumococcal conjugate vaccine (PCV): A cross sectional study at a district in India
by: Jayanta Majumder, et al.
Published: (2024-08-01)

Cost-effectiveness analysis of PCV20 to prevent pneumococcal disease in the Canadian pediatric population
by: Derek Lytle, et al.
Published: (2023-08-01)

Epidemiology of Streptococcus pneumoniae serotypes in children before and after pneumococcal vaccination
by: I. N. Protasova, et al.
Published: (2021-12-01)

Molecular Characterization and Antibiotic Susceptibility of Non-PCV13 Pneumococcal Serotypes among Vaccinated Children in Cape Coast, Ghana
by: Richael O. Mills, et al.
Published: (2022-10-01)

A decade of 10-valent pneumococcal conjugate vaccine use in Lithuania: trends in invasive pneumococcal serotype dynamics
by: Aurelija Petrutienė, et al.
Published: (2025-08-01)

Systematic review on serotypes distribution of pneumococcal pneumonia in adults and the elderly
by: Fatiha Mrabt, et al.
Published: (2025-03-01)

Recent Topics of Pneumococcal Vaccination: Indication of Pneumococcal Vaccine for Individuals at a Risk of Pneumococcal Disease in Adults
by: Nobuhiro Asai, et al.
Published: (2021-11-01)

The Impact of Pneumococcal Conjugate Vaccine (PCV) Coverage Heterogeneities on the Changing Epidemiology of Invasive Pneumococcal Disease in Switzerland, 2005–2019
by: Oluwaseun Rume-Abiola Oyewole, et al.
Published: (2021-05-01)

Invasive pneumococcal serotype 3 infection following pneumococcal vaccination in a hematopoietic stem cell transplant patient: A case report
by: Kazuhiro Ishikawa, et al.
Published: (2024-01-01)

Emergence of Streptococcus pneumoniae serotype 19A (Spn19A) in the pediatric population in Bogotá, Colombia as the main cause of invasive pneumococcal disease after the introduction of PCV10
by: Germán Camacho Moreno, et al.
Published: (2020-09-01)

PCV15, a pneumococcal conjugate vaccine, for the prevention of invasive pneumococcal disease in infants and children
by: Timothy J Chapman, et al.
Published: (2024-12-01)

SEROTYPE CHARACTERISTIC OF PNEUMOCOCCI ISOLATED FROM PATIENTS WITH PNEUMOCOCCAL MENINGITIS
by: I. S. Koroleva, et al.
Published: (2012-07-01)

Nasopharyngeal carriage of Streptococcus pneumoniae in children under 5 years of age before introduction of pneumococcal vaccine (PCV10) in urban and rural districts in Pakistan
by: Muhammad Imran Nisar, et al.
Published: (2018-12-01)